BetterScholar BetterScholar

Neil Bifulco

Cancer Discovery, Nature Microbiology, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Experimental and Molecular Therapeutics
9
Role
Title
Level Year L/R
🐜 First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
15 auth. M. Hagel, Chandrasekhar V. Miduturu, M. Sheets, Nooreen T. Rubin, W. Weng, Nicolas Stransky, Neil Bifulco, Joseph L. Kim, Brian L. Hodous, N. Brooijmans, ... A. Shutes, C. Winter, C. Lengauer, N. Kohl, T. Guzi 		7 2015
7
🐜
🐜 ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
26 auth. T. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, Brendan Chen, Neil Bifulco, H. Huynh, S. Lahiri, A. Shapiro, S. McLeod, Nicole M. Carter, Samir H. Moussa, Camilo Velez-Vega, N. Olivier, R. Mclaughlin, Ning Gao, ... Jason Thresher, T. Palmer, B. Andrews, R. Giacobbe, J. Newman, D. Ehmann, B. D. de Jonge, J. O’Donnell, John P. Mueller, R. Tommasi, Alita A. Miller 		7 2017
7
🐜
🐜 Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors.
7 auth. W. Kazmierski, Neil Bifulco, Hanbiao Yang, Larry Boone, F. Deanda, C. Watson, ... T. Kenakin 		6 2003
6
🐜
🐜 Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.
19 auth. Megan A. Hatlen, O. Schmidt-Kittler, C. Sherwin, E. Rozsahegyi, Nooreen T. Rubin, M. Sheets, Joseph L. Kim, Chandrasekhar V. Miduturu, Neil Bifulco, N. Brooijmans, ... Hongliang Shi, T. Guzi, A. Boral, C. Lengauer, M. Dorsch, R. Kim, Yoon-Koo Kang, B. Wolf, K. Hoeflich 		6 2019
6
🐜
🐬 The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 2: hydroxyindole derivatives.
Karen L. Milkiewicz, T. Marsilje, Richard P. Woodworth, Neil Bifulco, M. Hangauer, D. Hangauer 		3 2000
3
🐬
🐜 Substituted indanylacetic acids as PPAR-α-γ activators
30 auth. D. Lowe, Neil Bifulco, William H. Bullock, T. Claus, P. Coish, Miao Dai, F. D. Dela Cruz, David P. Dickson, Dongping Fan, H. Hoover-Litty, Tindy Li, Xin Ma, Gretchen Mannelly, M. Monahan, I. Muegge, ... S. O'connor, Mareli Rodriguez, T. Shelekhin, A. Stolle, Laurel J. Sweet, Ming Wang, Yamin Wang, C. Zhang, Hai‐Jun Zhang, Mingbao Zhang, Kake Zhao, Qian Zhao, Jian Zhu, Lei Zhu, M. Tsutsumi 		3 2006
3
🐜
🐜 Corrigendum to “Recent Progress in Discovery of Small–Molecule CCR5 Chemokine Receptor Ligands as HIV-1 Inhibitors” [Bioorg. Med. Chem. 2003, 11, 2663–2676]
7 auth. W. Kazmierski, Neil Bifulco, Hanbiao Yang, Larry Boone, F. Deanda, C. Watson, ... T. Kenakin 		2 2003
2
🐜
🐜 Recent Progress in Discovery of Small‐Molecule CCR5 Chemokine Receptor Ligands as HIV‐1 Inhibitors
7 auth. W. Kazmierski, Neil Bifulco, Hanbiao Yang, Larry Boone, F. Deanda, C. Watson, ... T. Kenakin 		2 2003
2
🐜
🐜 Abstract 1279: Development of a selective CDK2-E inhibitor in CCNE driven cancers
24 auth. Yoon-Jin Choi, S. Wenglowsky, Victoria Brown, Neil Bifulco, Y. Choi, Jian Guo, Megan A. Hatlen, Joseph L. Kim, T. LaBranche, Riadh Lobbardi, ... E. Perola, E. Rozsahegyi, Michelle A Maynard, P. Ramsden, Grace O. Silva, F. Stevison, R. Vargas, Ruduan Wang, Douglas Wilson, R. Woessner, Dean Zhang, R. Meißner, K. Hoeflich, M. Dorsch 		2 2021
2
🐜